
Alderley Park Ventures
Europe, Nottingham, United Kingdom, Nottingham'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
Description
Alderley Park Ventures is a £5M seed investment fund managed by BioCity following a significant contribution by AstraZeneca.
Investor Profile
Alderley Park Ventures has made 7 investments, with 0 in the past 12 months and 29% as lead.
Stage Focus
- Seed (57%)
- Series Unknown (14%)
- Series A (14%)
- Pre Seed (14%)
Country Focus
- United Kingdom (100%)
Industry Focus
- Biotechnology
- Health Care
- Biopharma
- Pharmaceutical
- Medical
- Artificial Intelligence (Ai)
- Data Integration
- Enterprise Software
- Information Technology
- Paas
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.